Lilleby W, Seierstad T, Inderberg EM, Hole KH(2023) Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring Int J Cancer(in press) DOI 10.1002/ijc.34448, PubMed 36715014
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK(2022) Correction: Melanoma - investigation and primary treatment Tidsskr Nor Laegeforen, 142(1) DOI 10.4045/tidsskr.22.0806, PubMed 36655962
Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM(2022) A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT) Front Oncol, 12, 1031232 DOI 10.3389/fonc.2022.1031232, PubMed 36439452